Literature DB >> 17540657

Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute.

Junko Nishimoto, Yasuyuki Amoh, Kenichi Tanabe, Nanako Niiyama, Kensei Katsuoka, Yoshimitsu Kuroyanagi.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17540657     DOI： 10.1684/ejd.2007.0225

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  7 in total

1.  A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute.

Authors:  Naoki Ohara; Shoji Mihara; Hiroyuki Nihara; Narihiro Akimoto; Naoki Madokoro; Mikio Kawai; Hideki Noda; Michihiro Hide; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2010-03-27       Impact factor: 1.731

2.  Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study.

Authors:  Giorgio Pajardi; Vicenzo Rapisarda; Francesco Somalvico; Andrea Scotti; Giulia Lo Russo; Francesco Ciancio; Arturo Sgrò; Manuela Nebuloni; Raffaele Allevi; Maria L Torre; Emilio Trabucchi; Mario Marazzi
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

3.  Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Authors:  Tomonori Taniguchi; Yasuyuki Amoh; Kenichi Tanabe; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-08-23       Impact factor: 1.731

4.  Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.

Authors:  Naoto Yamada; Eiju Uchinuma; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-12-03       Impact factor: 1.731

5.  Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.

Authors:  Akiko Hashimoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

6.  Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.

Authors:  Naoto Yamada; Eiju Uchinuma; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-07-06       Impact factor: 1.731

Review 7.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.